These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 9846282

  • 21. [Antimicrobial activities and mechanisms of carbapenem resistance in clinical isolates of carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter spp].
    Sugino Y, Iinuma Y, Nada T, Tawada Y, Amano H, Nakamura T, Hasegawa Y, Shimokata K, Shibata N, Arakawa Y.
    Kansenshogaku Zasshi; 2001 Aug; 75(8):662-70. PubMed ID: 11558128
    [Abstract] [Full Text] [Related]

  • 22. [Antimicrobial activities of meropenem against clinically isolated strains in 1999].
    Suzuki Y, Nishinari C, Endo H, Tamura C.
    Jpn J Antibiot; 2001 Apr; 54(4):145-70. PubMed ID: 11436501
    [Abstract] [Full Text] [Related]

  • 23. [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated from urine at one hospital to mainly carbapenem and fluoroquinolone drugs].
    Watanabe Y, Fujiue Y, Yano S, Shimizu S, Muroki K, Doi M, Kuwabara M.
    Jpn J Antibiot; 2006 Apr; 59(2):65-71. PubMed ID: 16805317
    [Abstract] [Full Text] [Related]

  • 24. [In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae].
    Fukuoka T, Inoue H, Abe T, Ohya S.
    Jpn J Antibiot; 2001 Jul; 54(7):365-71. PubMed ID: 11560055
    [Abstract] [Full Text] [Related]

  • 25. [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2009].
    Yamaguchi K, Ishii Y, Iwata M, Watanabe N, Shinagawa M, Yasujima M, Suwabe A, Kuroda M, Kaku M, Kitagawa M, Kanemitsu K, Imafuku Y, Murakami M, Yomodu S, Taniguchi N, Yamada T, Nomura F, Kanno H, Maesaki S, Hashikita G, Kondo S, Misawa S, Horiuchi H, Tazawa Y, Nakashima H, Takemura H, Okada M, Horikawa Y, Maekawa M, Nagura O, Yagi T, Baba H, Ishigo S, Fujita N, Komori T, Ichiyama S, Yamanaka K, Murata Y, Matsuo S, Kohno H, Kawano S, Kinoshita S, Taminato T, Negayama K, Murase M, Miyamoto H, Kusano N, Nose M, Yokozaki M, Itaha H, Matsunaga A, Yoshimura H, Kohno S, Yanagihara K, Matsuda J, Saikawa T, Hiramatsu K.
    Jpn J Antibiot; 2011 Apr; 64(2):53-95. PubMed ID: 21721247
    [Abstract] [Full Text] [Related]

  • 26. [Survey of sensitivities of clinical isolates to antibacterial agents (annual report)].
    Igari J, Inoue M, Nishino T, Watanabe N, Uehara N, Yoshida H, Imafuku Y, Shibano T, Satou S, Kobayashi I, Takahashi A, Yomoda S, Oguri T, Kumasaka K, Okada J, Hirata Y, Uchida K, Kawaguchi R, Ohtaki Y, Ishigo S, Okamoto E, Murakami E, Matsuoka K, Tokuda K, Saeki H.
    Jpn J Antibiot; 1997 Aug; 50(8):683-703. PubMed ID: 9339395
    [Abstract] [Full Text] [Related]

  • 27. Correlation between meropenem and doripenem use density and the incidence of carbapenem-resistant Pseudomonas aeruginosa.
    Shigemi A, Matsumoto K, Yaji K, Shimodozono Y, Takeda Y, Miyanohara H, Kawamura H, Orita M, Tokuda K, Nishi J, Yamada K.
    Int J Antimicrob Agents; 2009 Dec; 34(6):589-91. PubMed ID: 19748231
    [Abstract] [Full Text] [Related]

  • 28. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2000). I. Susceptibility distribution].
    Kumamoto Y, Tsukamoto T, Fujime M, Fujita K, Hirose T, Matsukawa M, Takahashi S, Kunishima Y, Igari J, Ogihara M, Ishibashi K, Oguri T, Shigeta S, Yamaguchi K, Matsumoto T, Kashitani F, Yoshida H, Imafuku Y, Murai M, Ooe H, Nishikawa M, Watanabe K, Kobayashi Y, Uchida H, Oka T, Kitamura M, Takano Y, Matsuoka Y, Matsuda S, Sato S, Furuhama T, Kumon H, Monden K, Aoki S, Mochida C, Hirakata Y, Kohno S, Miyazaki Y, Tomono K.
    Jpn J Antibiot; 2002 Aug; 55(4):370-98. PubMed ID: 12378869
    [Abstract] [Full Text] [Related]

  • 29. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2001). I. Susceptibility distribution].
    Kumamoto Y, Tsukamoto T, Watanabe K, Kobayashi Y, Matsukawa M, Uchida H, Kunishima Y, Hirose T, Matsuda S, Sato S, Shigeta S, Fujime M, Fujita K, Yamaguti O, Ogihara M, Ishibashi K, Igari J, Takahashi K, Oguri T, Yoshida H, Imafuku Y, Yamaguchi K, Furuya N, Kashitani F, Murai M, Ooe H, Nishikawa M, Kumon H, Monden K, Oka T, Kitamura M, Kohno S, Tomono K, Miyazaki Y, Matsuoka Y, Fukuhara Y, Hirakata Y, Aoki S.
    Jpn J Antibiot; 2003 Oct; 56(5):396-423. PubMed ID: 14692378
    [Abstract] [Full Text] [Related]

  • 30. [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2002].
    Yamaguchi K, Ishii Y, Iwata M, Yoshida H, Satoh T, Watanabe N, Uehara N, Murakami M, Takahashi A, Yasujima M, Kasai T, Itoh K, Shibuya Y, Suwabe A, Obata R, Kanno H, Kubo S, Kaku M, Kanemitsu K, Maesaki S, Hashikita G, Igari J, Oguri T, Aihara M, Kinoshita S, Okada J, Tazawa Y, Taminato T, Negayama K, Nakashima H, Takemura H, Murase M, Miyamoto H, Horii T, Kusano N, Mihara E, Baba H, Ishigo S, Kambe M, Itaha H, Fujita N, Komori T, Ono J, Yoshimura H, Ichiyama S, Maeda S, Hirakata Y, Matsuda J, Yamanaka K, Murata Y, Saikawa T, Hiramatsu K.
    Jpn J Antibiot; 2004 Feb; 57(1):70-104. PubMed ID: 15116574
    [Abstract] [Full Text] [Related]

  • 31. [In vitro and in vivo antibacterial activities of pazufloxacin mesilate, a new injectable quinolone].
    Nomura N, Mitsuyama J, Furuta Y, Yamada H, Nakata M, Fukuda T, Yamada H, Takahata M, Minami S.
    Jpn J Antibiot; 2002 Aug; 55(4):412-39. PubMed ID: 12378871
    [Abstract] [Full Text] [Related]

  • 32. Combined effects of the siderophore monosulfactam BAL30072 and carbapenems on multidrug-resistant Gram-negative bacilli.
    Hofer B, Dantier C, Gebhardt K, Desarbre E, Schmitt-Hoffmann A, Page MG.
    J Antimicrob Chemother; 2013 May; 68(5):1120-9. PubMed ID: 23344577
    [Abstract] [Full Text] [Related]

  • 33. Survey of antibiotic susceptibility among gram-negative bacilli at a cancer center.
    Rolston KV, Elting L, Waguespack S, Ho DH, LeBlanc B, Bodey GP.
    Chemotherapy; 1996 May; 42(5):348-53. PubMed ID: 8874974
    [Abstract] [Full Text] [Related]

  • 34. [In vitro activity of six beta-lactams against 295 strains of enterobacteriaceae and P. aeruginosa isolated from neutropenic patients].
    Maugein J, Perrier F, Cony Makhoul P, Fourche J, Darmaillac V.
    Pathol Biol (Paris); 1995 Apr; 43(4):253-7. PubMed ID: 7567110
    [Abstract] [Full Text] [Related]

  • 35. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution].
    Kumamoto Y, Tsukamoto T, Hirose T, Yokoo A, Hikichi Y, Shigeta S, Takanashi T, Shiraiwa Y, Ogiwara M, Yoshida H, Imafuku Y, Murai M, Watanabe K, Uchida H, Kobayashi Y, Matsuda S, Fujime M, Fujita K, Igari J, Oguri T, Kosakai N, Yamaguchi K, Matsumoto T, Kashitani F, Tanaka M.
    Jpn J Antibiot; 1997 Mar; 50(3):219-50. PubMed ID: 9575353
    [Abstract] [Full Text] [Related]

  • 36. [Rapid bactericidal activities of carbapenems against Pseudomonas aeruginosa in simulating human plasma concentrations].
    Ishii C, Kakuta M, Abe T, Fukuoka T, Inoue M.
    Jpn J Antibiot; 2002 Apr; 55(2):187-95. PubMed ID: 12071096
    [Abstract] [Full Text] [Related]

  • 37. [Changes in the antibacterial activity of chemotherapeutic agents (especially carbapenems) for 10 species of clinical isolates between 1994 and 1996. Surveillance group of the sensitivities of clinical isolates to antibacterial agents].
    Igari J, Watanabe N, Uehara N, Inoue M, Yoshida H, Imafuku Y, Nishino T, Shibano T, Satou S, Kobayashi I, Takahashi A, Yomoda S, Matsuoka K, Oguri T, Ohba Y, Kumasaka K, Tokuda K, Kobayashi Y, Hongo T, Okada J, Sasaki T, Matsumoto N, Hirata Y, Nakasaki N, Ono J, Takata T, Kawaguchi R, Ohtaki Y, Kajimura K, Ishigo S, Hashimoto T, Aoki N, Okamoto E, Murakami E, Saeki H.
    Jpn J Antibiot; 2000 Mar; 53(3):157-70. PubMed ID: 10834147
    [Abstract] [Full Text] [Related]

  • 38. Comparative in vitro activity of meropenem versus other extended-spectrum antimicrobials against randomly chosen and selected resistant clinical isolates tested in 26 North American centers.
    Pitkin DH, Sheikh W, Nadler HL.
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S238-48. PubMed ID: 9126699
    [Abstract] [Full Text] [Related]

  • 39. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Shimizu Y, Terai T, Inoue H, Nakadate T, Ito C, Yoshida T, Ohno I, Tanno Y, Arakawa M, Igarashi K, Okada M, Ozaki K, Aoki N, Kitamura N, Sekine O, Suzuki Y, Nakata K, Nakatani T, Inagawa H, Kusano N.
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [Abstract] [Full Text] [Related]

  • 40. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
    Thabaut A, Meyran M, Huerre M.
    Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.